Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT

被引:2
|
作者
Alem-Bezoubiri, Asma [1 ]
Ameir Suleiman, Suleiman [2 ]
Behidj, Ikram [3 ]
Mazrou, Hakim [4 ]
Chami, Ahmed Chafik [5 ]
机构
[1] Algiers Nucl Res Ctr CRNA, Med Phys Dept, Radiol Phys Div, 02 Blvd Frantz Fanon,BP 399 Alger RP, Algiers 16000, Algeria
[2] Tanzania Atom Energy Commiss, Radiat Control Directorate, POB 743, Arusha, Tanzania
[3] Cent Army Hosp, Radiotherapy Serv, Algiers, Algeria
[4] Algiers Nucl Res Ctr CRNA, Div Environm Safety & Radioact Waste, 02 Blvd Frantz Fanon,BP 399 Alger RP, Algiers 16000, Algeria
[5] Univ Sci & Technol Houari Boumediene, Fac Phys, USTHB, BP 32 EL ALIA, Algiers, Algeria
关键词
Prostate cancer; Secondary cancer risk; External beam radiotherapy; 3D conformal radiotherapy; Monte Carlo study; Out-of-field dose; DYNAMIC MLC IMRT; OF-FIELD ORGAN; LINEAR-ACCELERATOR; PROTON THERAPY; RADIOTHERAPY; SPECTRA; MV; PHANTOM; SIMULATION; EQUIVALENT;
D O I
10.1016/j.apradiso.2021.110065
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The present study aimed to evaluate organ doses and related risk for cancer from scattered neutrons involving 3D Conformational Radiotherapy (3D-CRT) for patients with prostate cancer in Algeria based on Monte Carlo technique and to estimate the secondary cancer risks. To this purpose, a detailed geometric Monte Carlo (MC) modeling of the LINAC Varian 2100C combined with a computational whole-body phantom was carried out. The neutron equivalent doses were calculated in-field and out-of field of patient's organs using the phase-space method. The obtained neutron equivalent doses were used to estimate the Lifetime Attributable Risks (LARs) for cancer incidence in out of field organs. LARs was evaluated assuming Biological Effects of Ionizing Radiation VII (BEIR VII) risk model for exposure age in the range 35-70 years, according to the interval's age of treated patients in Algeria. The baselines cancer risks and survival data were associated with the statistical data for the Algerian population. The results showed that the neutrons equivalent doses per prescribed dose (Photon Dose) mostly depend on the distance of organs from the treated volume. The highest and lowest equivalent doses of 1.18 mSv/Gy and 0.25 mSv/Gy were recorded in the bladder and heart, respectively. The highest estimated lifetime attributable risk per 100,000 population was found for 35 yrs' exposure age in colon 49.94, lung 16.63 and stomach 11.17. The lowest risks were found for 70 yrs' age, in spine 0.06 and thyroid 0.14. The results showed that LARs values decrease with the increase of the exposure age and cancer incidence risk is lower than the baseline cancer risk incidence for all organs. The present study may help in providing a database on the impact of radiotherapy-induced secondary cancer incidence during 3D-CRT for prostate cancer in Algeria.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Risk Estimation of Radiation Induced Second Cancers in Prostate Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT) and Three Dimensional Conformal Radiotherapy (3D-CRT)
    Sakulsingharoj, S.
    Boonkitticharoen, V.
    Tannanonta, C.
    Kakanaporn, C.
    Iampongpaiboon, P.
    MEDICAL PHYSICS, 2009, 36 (06) : 2637 - +
  • [42] COMBINATION OF 3D-ULTRASOUND AND MONTE CARLO DOSE CALCULATION FOR ACCURATE ASSESSMENT OF DOSES DELIVERED DURING DAILY RADIATION THERAPY FOR PROSTATE CANCER
    Cury, F.
    Chen, Y.
    Fraser, D.
    Parker, W.
    Shenouda, G.
    Souhami, L.
    Faria, S.
    Duclos, M.
    David, M.
    Verhaegen, F.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S30 - S30
  • [43] Monte Carlo calculation of imaging doses from diagnostic multidetector CT and kilovoltage cone-beam CT as part of prostate cancer treatment plans
    Ding, Aiping
    Gu, Jianwei
    Trofimov, Alexei V.
    Xu, X. George
    MEDICAL PHYSICS, 2010, 37 (12) : 6199 - 6204
  • [44] Predictors of rectal acute toxicity in high-dose 3D-CRT for prostate cancer. Results from a prospective multi-centric study performed by the AIRO national working group on prostate irradiation
    Valdagni, R
    Vavassori, V
    Fiorino, C
    Rancati, T
    Magli, A
    Fellin, G
    Cagna, E
    Mauro, F
    Munoz, F
    Franzone, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S287 - S288
  • [45] Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk
    Fenoglietto, Pascal
    Laliberte, Benoit
    Allaw, Ali
    Ailleres, Norbert
    Idri, Katia
    Hay, Meng Huor
    Moscardo, Carmen Llacer
    Gourgou, Sophie
    Dubois, Jean-Bernard
    Azria, David
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 (01) : 77 - 87
  • [46] A comparative planning study on the treatment of gastric cancer patients with tomotherapy, coplanar and non-coplanar three-dimensional conformal radiotherapy (3D-CRT)
    Kazemzadeh, A.
    Mahani, L.
    Kianinia, M.
    Shanei, A.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (04):
  • [47] Design study on photoacoustic probe to detect prostate cancer using 3D Monte Carlo simulation and finite element method
    El-Gohary S.H.
    Metwally M.K.
    Eom S.
    Jeon S.H.
    Byun K.M.
    Kim T.-S.
    Biomedical Engineering Letters, 2014, 4 (3) : 250 - 257
  • [48] A phase I trial of intraprostatic injection of CG7870 and 3d-conformal radiation therapy (3D-CRT) in patients with localized intermediate risk prostate cancer: Integrated oncolytic adenovirus and radiationmechanisms of interaction
    Senzer, N
    Corman, J
    Nemunaitis, J
    Ando, D
    Kirn, D
    Yu, DC
    Burke, J
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S54 - S55
  • [49] Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy)
    Aoki, Manabu
    Miki, Kenta
    Kido, Masahito
    Sasaki, Hiroshi
    Nakamura, Wataru
    Kijima, Yoshikazu
    Kobayashi, Masao
    Egawa, Shin
    Kanehira, Chihiro
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (03) : 527 - 532
  • [50] Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)
    Michalski, J. M.
    Moughan, J.
    Purdy, J. A.
    Bosch, W. R.
    Bahary, J.
    Lau, H.
    Duclos, M.
    Parliament, M.
    Morton, G.
    Hamstra, D. A.
    Seider, M.
    Lock, M. I.
    Patel, M.
    Gay, H. A.
    Vigneault, E.
    Dignam, J.
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (05): : 1263 - 1263